Literature DB >> 12884166

Human illness associated with use of veterinary vaccines.

Ruth L Berkelman1.   

Abstract

Veterinary vaccines are being used with increasing frequency in the United States to protect the health of animals. However, humans may be inadvertently exposed to these products by means of unintentional inoculation or other routes of exposure. The potential for both exposure and for adverse consequences secondary to exposure to veterinary vaccines may be growing. With the exception of brucellosis vaccines, there have been few reports of suspected or confirmed adverse events in humans associated with the use of animal vaccines, but it is unclear whether that is because few adverse events occur or because adverse events are not recognized and/or reported. Results of a search for relevant literature and of communications with health officials at governmental and private institutions suggest that enhanced efforts are needed to recognize and to prevent human illness associated with use of veterinary vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884166     DOI: 10.1086/375595

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis.

Authors:  Karen B Register; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

Review 2.  Bordetella bronchiseptica pneumonia: beware of the dog!

Authors:  Jamie Clements; Christopher McGrath; Charlie McAllister
Journal:  BMJ Case Rep       Date:  2018-04-27

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Melissa M Kahl-McDonagh; Allison C Rice-Ficht
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

5.  Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses.

Authors:  Zhiqiang Li; Hui Zhang; Jinliang Zhang; Li Xi; Guangli Yang; Shuli Wang; Qingfeng Zhou; Xiaogen Zhang; Junbo Zhang
Journal:  World J Microbiol Biotechnol       Date:  2018-01-04       Impact factor: 3.312

6.  Rapid and reliable single nucleotide polymorphism-based differentiation of Brucella live vaccine strains from field strains.

Authors:  Krishna K Gopaul; Jessica Sells; Betsy J Bricker; Oswald R Crasta; Adrian M Whatmore
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  Brucella melitensis 16MΔTcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection.

Authors:  Zhiqiang Li; Junbo Zhang; K E Zhang; Qiang Fu; Zhen Wang; Tiansen Li; Hui Zhang; Fei Guo; Chuangfu Chen
Journal:  Exp Ther Med       Date:  2015-07-06       Impact factor: 2.447

8.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

9.  A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.

Authors:  Junbo Zhang; Shuanghong Yin; Fei Guo; Ren Meng; Chuangfu Chen; Hui Zhang; Zhiqiang Li; Qiang Fu; Huijun Shi; Shengwei Hu; Wei Ni; Tiansen Li; Ke Zhang
Journal:  J Microbiol       Date:  2014-07-04       Impact factor: 3.422

10.  Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Donald S Davis; Philip H Elzer; Alfredo Wong-Gonzalez; Allison C Rice-Ficht
Journal:  J Wildl Dis       Date:  2009-01       Impact factor: 1.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.